Globe Life (GL) CEO Frank Svoboda Sells $1.6M of Stock

Frank Svoboda Trades Globe Life Stock Again

Globe Life Inc. NYSE GL Co-Chairman and CEO Frank Svoboda sold 10,000 shares of company stock on June 11, 2026. The transaction took place at an average price of $164.89, bringing the total value of the sale to roughly $1.65 million. This trade follows a matching purchase of 10,000 shares by the executive on the exact same day at a price of $100.74 per share, highlighting a complex pattern of overlapping insider transactions at the top level of the firm.

More Executive Moves at Globe Life

This executive transaction joins a busy stretch of insider activity for the insurer. On June 30, 2026, EVP and Chief Administrative Officer Dolores Skarjune executed both a purchase and a sale of 1,850 shares. She bought her stake at $103.23 per share for a value of $190,975.50 and later sold a matching block at $179.18 per share worth $331,483. Similarly, EVP and Chief Talent Officer Rebecca Zorn completed dual transactions on June 18, 2026, acquiring 2,000 shares at $98.32 before parting with a separate block of 2,000 shares.

Valuation and Stock Price Levels

The insurer's shares trade at $166.76, positioned below its 50-day moving average of $177.17 but holding above its 200-day moving average of $155.94. The company currently carries a price-to-earnings ratio of 11.45 alongside a forward P/E of 10.42. These levels place the stock near the middle tier of its 52-week trading bounds, which stretch from a low of $127.85 up to a high of $191.55.

Analysts Set New Price Targets

Financial institutions have kept a close watch on the insurer with frequent updates to their price objectives. On October 15, 2026, JP Morgan maintained its Overweight rating and set a $195.00 target, stepping up from its previous view. Wells Fargo kept an Overweight rating on October 12, 2026, lifting its target to $191.00. Earlier in the month on October 5, 2026, Morgan Stanley kept an Overweight rating while adjusting its target to $197.00. Across eleven analyst opinions, the company holds a consensus target mean price of $193.91, with individual targets stretching from a low of $166.00 to a high of $225.00.

What Globe Life Does

Based in McKinney, Texas, Globe Life provides various life and supplemental health insurance products targeted at lower-middle and middle-income families across the United States. The firm operates through direct channels, independent brokers, and exclusive agents to deliver whole life, term life, Medicare supplement, and limited-benefit health coverage. Founded in 1900, the company handles its insurance operations through dedicated subsidiaries.

Looking Ahead for the Insurer

Investors will look toward the company's next earnings report, slated for October 21, 2026, for fresh details on financial performance and segment revenue. While insider transactions provide insight into how executives manage their personal holdings, these filings reflect individual choices rather than broad directional signals for the equity.